Advertisement

Organisation › Details
Weezion SAS
Weezion SAS is the result of a scientific partnership between the teams of the Institute of Infectious Agents at the Croix Rousse Hospital in Lyon, the Institute of Analytical Sciences, and the International Infectious Disease Research Centre of the Claude Bernard Lyon 1 University. Co-founded by François Vandenesch, Jérôme Lemoine and Hervé Brochette, Weezion develops and promotes innovative solutions for the in-vitro diagnosis of micro blood infections, created within the framework of IdBIORIV, winner of the “Hospital-University Research in Health (RHU)” project of the Investments for the Future Program. *
![]() |
Start | 2020-09-18 established (s-off) |
![]() |
Industry | in vitro diagnostics (IVD) |
Industry 2 | Weezion dx technology | |
![]() |
Person | Brochette, Hervé (Weezion 202205 CEO + Co-Founder) |
![]() |
Region | Lyon |
Country | France | |
Street | 30 Route de la Gorge aux Loups | |
City | 71960 Vergisson | |
Address record changed: 2022-06-01 | ||
Basic data | Employees | n. a. |
* Document for »About Section«: Weezion SAS. (6/1/22). "Press Release: Weezion, a French MedTech Start-up, Announces Capital Investment from bioMérieux". Lyon. | ||
Record changed: 2024-03-30 |
Advertisement

More documents for Weezion SAS
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to info@iito.de and simply fill the subject line with the word »MSC Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at Life-Sciences-Germany.com and Life-Sciences-Europe.com
Advertisement

» top